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Abstract
The baseline standards for minimally acceptable science are improving as the understanding of the scientific method improves. Journals
publishing research papers are becoming more and more rigorous. For example, in 2001 a group of authors evaluated the quality of clinical trials in
anesthesia published over a 20 year period [Pua et al., Anesthesiology 2001;95:1068–73]. The authors divided the time into 3 subgroups and
analyzed and compared the quality assessment score from research papers in each group. The authors reported that the scientific quality scores
increased significantly in this time, showing more randomization, sample size calculation and blinding of studies. Because every journal strives to
have a high scientific impact factor, research quality is critical to this goal. This means novice researchers must study, understand and rigorously
avoid the common mistakes described in this review. Failure to do so means the hundreds and hundreds of hours of effort it takes to conduct and
write up a clinical trial will be for naught, in that the manuscript with be rejected or worse yet, ignored. All scientists have a responsibility to
understand research methods, conduct the best research they can and publish the honest and unbiased results.
# 2010 Japan Prosthodontic Society. Published by Elsevier Ireland.
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OThis review of the literature will describe the 15 common
mistakes that novice researchers often make when planning
conducting and writing up a clinical research project. These
mistakes are usually made during the design phase; but might
also be made during the data collection, analysis or manuscriptpen access under CC BY-NC-ND license.
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research project and publication are suggested.
1. Failure to carefully examine the literature for
similar, prior research
All research begins with the idea or question. What young or
novice researchers often fail to appreciate is that the questions
they take an interest in are likely not to be new, but are actually
questions that others have thought of and frequently have made
attempts to investigate in the past. The way to avoid this
mistake is to assume that the question of interest has already
been studied and the first job in the research design process is to
exhaustively pursue, find and then catalog what has been
published. Of course, the novice researcher may have a new
variation of the question, or they may be using a new
methodology or examining a new population of patients, but it
should always be assumed that the core question in some form
is likely to have been addressed previously. It now becomes the
novice investigator’s job to find that information, and consider
the positive and negative outcomes of the prior studies in the
new research design development.
HINT 1: When selecting and refining the exact focus of a
question it is critically important for the novice to read in detail
the discussion section of similar articles, for in that portion of
the paper, most researchers speculate on what needs to be
accomplished next in that topical area to advance the science.
2. Failure to critically assess the prior literature
Onceawise novice researcher has systematically accumulated
and categorized the literature concerning the question of interest,
the next step is to carefully examine the research papers related to
the questionof interest tofindoutwhat prior researchers felt could
have been improved.One strategy to achieve this is to put together
a team or group of research colleagues and select the 10–15 most
important articles on a topic for the team to review. Ask each
member of the team to present a critical analysis of the literature
assigned, presenting both the good and bad points. Developing an
individual’s critical analysis skills will aid novices greatly in
designing studies that minimize error. Not only is it necessary to
critically analyze the literature before designing a new research
project, but it is necessary to include these critical remarks in the
introductory section of the resulting final manuscript in order to
justifywhy the studywas needed andwhat you as a researcher did
better than previous researchers.
HINT 2: There is an old adage that says: ‘‘those who forget
history are doomed to repeat it’’ and it is applicable to research
as well. Investigators who repeat work previously done and do
not recognize and build on prior efforts are likely to find their
work unpublishable.
3. Failure to specify the inclusion and exclusion criteria
for your subjects
A common omission from many research papers is the
lack of research subject specifications, namely the inclusionand exclusion criteria. Listing these criteria helps other
researchers understand why current results might differ from
other published studies. For example your patient population
might be younger or your patient population might be from a
different racial group or have a different ratio of males to
females than were used in other research studies. In any case,
it is necessary to specify as best you can the make-up of your
subjects. This includes specific criteria for exclusion if you
have any. Once you have the inclusion and exclusion criteria,
be sure that you actually follow these criteria in selecting
subjects for your study.
HINT 3: If a novice researcher is not sure how to develop a
list of inclusion and exclusion criteria for a specific research
question, look at prior research and use criteria that other
researchers have specified.
4. Failure to determine and report the error of your
measurement methods
Very few research reports actually provide more than a
single sentence saying their examiners were calibrated. They
rarely specify the method of training, the standards of
performance and the frequency of re-assessment of their
putatively calibrated examiners. All methods need replication
and every researcher who is attempting the research project
needs to be able to answer the question, ‘‘What is the error of
your measurement method?’’ Some researchers refer to prior
publications when answering this question but a good
researcher knows the exact error of his/her own measurement
methods and the inter-examiner variation. To find this error
value involves conducting a small test-retest experiment. If
however a researcher is using multiple examiners to help collect
data, these examiners need to be calibrated to a known standard
before being given the go-ahead to begin making measure-
ments. If the research project is a long-term project, i.e. lasting
for many months or years, it is critical to have examiners who
are calibrated and re-calibrated periodically to an accepted
standard of performance. Often extensive, complex and
difficult studies fail because of the lack of detail to this small
issue. A 2001 article examined the effects of measurement error
on therapeutic equivalence trials and reported that measure-
ment errors inappropriately favor the goal of showing treatment
equivalence [1]. Essentially, this article reported on how
imprecise data makes it difficult to tell if there are any real
differences between two methods or two treatments. Such
imprecision is a disadvantage if your goal is to evaluate that a
new method of treatment is better than the old method;
however, if you want to show that the new method or treatment
is equivalent to or as good as the old treatment then imprecise
data benefits this goal of showing equivalence or non-
superiority. Another study in 2008 examined the frequency
and characteristics of data entry errors in large clinical
databases [2]. These authors reported that error rates ranged
from 2.3 to 26.9%, with the errors being not just mistakes in
data entry but many non-random, clusters that could potentially
affect the study outcome.
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process an independent research endeavor that could result in a
publication of the process in a scientific journal.
5. Failure to specify the exact statistical assumptions
made in the analysis
Since most studies will include statistical analysis of the
data, specifying the level of significance (called the alpha level)
that is acceptable and the exact statistical tests methods used is
common place. However, rarely do you see the authors stating
what they used as their beta value (type II error) which indicates
their chance of a type II error (usually beta is 0.2 or less). The
reciprocal of beta (1minus beta) is then converted to a percent
and reported as the power of a study (usually 80%). Novice
researchers often do not state the directionality of the testing
that they perform, namely whether they are using a one-tailed or
two-tailed analysis. In 2007, an excellent review of the
literature was published which cataloged and described 47
specific statistical mistakes that are commonly made in the
medical literature [3]. These authors strongly suggested
involving a statistical consultant early in a study as a way to
prevent some of these common mistakes.
HINT 5: Providing statistical test assumption details gives
the reader/reviewer the sense that the authors are attentive to
detail and honest in describing the research process and the lack
of such detail implies the opposite.
6. Failure to perform sample size analysis before the
study begins
Most clinical trials that claim two methods are equivalent (or
non-superior) are underpowered, whichmeans they have too few
subjects. To avoid this mistake, prior to initiation of a research
project, it is important to know howmany subjects are needed to
achieve the minimum power level desired. There are multiple
online and commercial computer based programs that will, with
minimum information, provide the user with both the power and
the estimated group sample size. To achieve sample size analysis
it is necessary to understand the nature of the data that is to be
collected, i.e. is thedata linear or non-linear. It is alsonecessary to
have a reasonable estimate ofwhat effect the interventionwill be,
called the effect size. Finally it is essential to understand the
variability of data collected. Without knowing the variability of
the data, the effect size, and the power that is expected, it is
impossible to estimate sample size, but with these data sample
size estimation can easily be achieved. In a 2001 paper, the topic
of equivalency testing and sample size in dental clinical trialswas
examined [4]. Specifically these researchers examined studies
that compared the efficacy of dentures supported by 2 implants
versus dentures supported by 4 implants. Such a study design is
called an equivalency study. If the 2 methods are found to be
equivalent, then one would logically recommend the use of the
simpler and less expensive method. The authors found that
underpowering a study makes it easier to find equivalency.
HINT 6: For linear data, if the standard deviation is quite a
bit larger (e.g. 2–3 times larger) than the difference between the2 treatment groups, the sample size required to show
significance goes up substantially.
7. Failure to implement adequate bias control measures
The single most important mistake that clinical researchers
make is the failure to implement adequate bias control
measures. Bias control is what distinguishes good from bad
research and measures to control for bias include: randomiza-
tion of subjects to the areas, interventions and control
conditions: measurement and analysis of subjects with the
investigators blind to the subject status; and having a credible
control condition and verifying at the onset and along the way
that the subject is truly blind to the group to which they were
assigned. This process is called a blinding status check. Double-
blinding of researchers and subjects is desirable in a clinical
trial to decrease bias. When blinding is not used or when the
subject group status is easily detected, subjects will generally
try to fulfill the perceived expectations of the researcher. The
issue of expectation fulfillment was first pointed out in a study
in Hawthorne, Michigan at an electronics plant [5]. The
experimenters varied the intensity of electrical lighting
available in the plant to see if there was a cause and effect
relationship between work productivity and light intensity.
Fortunately they varied the electric lighting in both directions,
increasing the intensity and decreasing the intensity. What they
discovered is that whenever an experiment was being
conducted, work productivity increased; thus the phrase ‘‘the
Hawthorne Effect’’ entered our scientific lexicon. This term
means that any subject is likely to perform to the investigator’s
expectations if they are not blind to their status. In 2001 a study
examined the influence of study size on study outcome [6].
Specifically a meta-analysis reviewed 190 randomized trials
involving 8 different therapeutic interventions divided the
various studies into those with more than 1000 participants and
those with less than thousand participants. The results of this
analysis were that the smaller sized studies had more positive
therapeutic effects than those studies with the larger size. These
researchers also reported that the larger studies were system-
atically less likely to report a positive effect, suggesting bias
was easier to occur and have an impact in smaller studies. These
researchers also looked at other bias control measures such as
randomization and blinding and concluded that inadequate
randomization and blinding leads to exaggerated estimates of
the intervention’s benefit.
HINT 7: Patient’s are remarkably able to detect to which
group they have been assigned even though the blinding
measures have been implemented; therefore good studies
always perform periodic blinding checks.
8. Failure to write and stick to a detailed time line
A detailed timeline or Gantt chart is an essential feature to
include in a protocol of a clinical trial. These charts can be
created using a Microsoft Office Excel spreadsheet and every
step of the trial should be noted in the timeline. The problem
often seen with novice researchers is that they lack experience
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specific task. Nevertheless, a timeline is a critical and important
overall feature in clinical studies, and failure to create and
follow the timeline is a common mistake that is frequently
made in clinical research.
HINT 8: Good researchers make a timeline plan that
includes critical benchmarks along the way, they post it on the
wall for everyone to see and they stick to it!
9. Failure to vigorously recruit and retain subjects
Clinical research implies that human subjects will be
involved in the study. Subjects must be identified and recruited
and a plan for this recruitment process needs to be developed
and written down. A 2009 study actually compared 3 methods
of subject recruitment and reported that direct telephone calls to
the patient by the investigator were the most effective method
[7]. Failure to have a specific recruitment plan and a method for
retaining subjects in the study is a common mistake. Moreover,
since subject recruitment is often a major issue in research
studies, there should be more than one plan for subject
recruitment.
HINT 9: Well designed research often fails because of poor
subject recruitment and retention procedures so make this a
priority.
10. Failure to have a detailed, written and vetted
protocol
Before you begin any research project, especially clinical
research, a fully developed protocol is critical. Novice
researchers often begin research without completing the
protocol. Moreover, in addition to writing the protocol, the
researcher needs to present the protocol to a peer group,
hopefully a peer group with moderate research experience,
with the request that the group provide critical comments and
suggestions for improvement. There is an old saying ‘‘luck
favors the well prepared’’. In the field of research, being well
prepared means a well thought out, detailed written protocol
is available and consulted frequently during the conduct of
the clinical research project. Once the second phase of the
research project starts, the data analysis phase, it is critical
that an appropriate statistical methodology be selected and
implemented to effectively analyze the data. Typically an
experienced clinical researcher will consult a statistician for
advice both before beginning the research and after the data
has been collected. In the research phase a statistician is
critical in helping to conceptualize the analytical methodol-
ogy that should be used. Ideally the consultation with the
statistician needs to continue as the data is being collected
and prior to final analysis of the data. In many ways, the
statistician serves as an outside auditor attesting to the
diligence and honesty of the research process and analysis. It
is not uncommon that the data that was planned to be
collected, changes for pragmatic and unexpected reasons.
This means the analytical plan may need to be adjusted.
Although statistical software programs have improvedimmensely in the last 10 years, no software program can
make up for inappropriate or inexact design of a research
project so consultation with an experienced statistician is
almost always a necessity. In 2001, a review paper was
written which discussed the topic of optimal clinical
research design for chronic pain drug efficacy studies [8].
The authors made a list of suggestions that researchers
should consider when they design and conduct such studies,
but in their conclusions, they strongly suggested that a
biostatistician consultant be used throughout all phases of the
clinical trial.
HINT 10: The adage that is applicable here is: ‘‘the devil is
in the details!’’ This saying refers to the fact that getting a
general understanding and agreement that a project will be
conducted is not enough. A researcher must also achieve a
thorough understanding and agreement on the specifics of the
project, which must be adequately documented or it can easily
fail.
11. Failure to examine for normality of the data
In the analytic phase, it is important to examine the data that
has been collected to see if it is normally distributed. Normality
is a concept that applies to continuous linear data and is not
applicable to categorical or non-linear dichotomous data. There
are statistical programs that will take a data set and examine
whether it meets the standards of normality. Data that is
unevenly distributed about the mean can sometimes be
transform into more equally distributed data by using a log
or log–log transformation The advantage of transforming the
data is that it allows you to continue using parametric statistical
methods, as opposed to using non-parametric statistical
analysis methods. In general, parametric statistical analysis
is a more sensitive method (i.e. has more statistical power) and
is preferred over that used to analyze non-parametric data.
HINT 11: A researcher should always look at the raw data
obtained from the study displayed graphically since this
demonstrates areas where there are problems with the data. The
goal is to see if a histogram of the data demonstrates a bell-
shaped curve or some other figure.
12. Failure to report missing data, dropped subjects
and use of an intention to treat analysis
Statistical consultants will most likely recommend analy-
tical methods that are consistent with an intention to treat
methodology. This methodology deals with dropouts. Often
novice researchers exclude dropouts from the analysis, and this
can alter the conclusions of the study. Regardless of the method
of analysis used, it is critical to report all dropped data, missing
data, and subject dropouts in a careful and honest fashion. How
the project dealt with lost or dropped data must be included in
the methods section of the research report. Clinical trials that
involve complicated, difficult or prolonged protocols often
suffer from subject dropout. Many researchers will implement
inclusion and exclusion criteria that reasonably eliminate the
non-compliant patient. For example exclusion criteria might
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questionnaire will be excluded from this study’’ or ‘‘subjects
that failed to appear for more than one follow-up visit will be
excluded’’. Sometimes researchers will see the potential
clinical subjects more than once during the pre-enrollment
phase to determine their eligibility. This pre-enrollment phase
frequently is referred to as the run-in phase. A run-in phase in a
clinical study is an advantage in that it is easier to identify
subjects who are likely to be non-compliant with the protocol
and would best be excluded before enrollment. Clearly such a
strategy would result in fewer dropouts, which is highly
desirable. Unfortunately, run-in designs with many exclusions,
make the results less generalizeable to the real world population
of subjects. Often such trade-offs are made between
practicality, and idealism in design. In 1998 a small study
was published describing the advantages and disadvantages of a
run-in phase to a research protocol [9]. The authors concluded
that run in clinical trials overestimate the benefits and
underestimate the risks of treatment.
HINT 12: If you have to choose between excluding subjects
and having many drop-outs, always choose excluding.
13. Failure to perform and report power calculations
Novice researchers often fail to perform a power calculation
on their study. Such a calculation is critical in studies of
equivalency. Small studies with low power often find no
significant differences between the treatment interventions,
however, if the study was inadequately powered then a type II
error is more likely. A type II error is the acceptance of a false
negative hypothesis. There are in fact multiple software
programs that allow researchers to determine the power of their
results. In 2001 an article examined how often underpowered
reports of equivalency occurred in the surgical literature [10].
Specifically these authors looked at randomized controlled
trials, where the control treatment was an active intervention,
usually the standard treatment of the day. In these studies a new
treatment was compared to the standard treatment and
considered to be equal to the standard treatment if the results
were equivalent. These researchers looked at 90 randomized
controlled trials in the surgical literature and found that 39% of
these reports met the standards for equivalency. The other 61%
of the reports were typically underpowered and thus subject to a
type II error. In 2001 another paper, examined type II error rates
in the orthopedic trauma literature [11]. Similar to the results
published in the prior study, 90% of this literature was
underpowered with the overall power calculated for the 117
papers reviewed being 25%. The standard acceptable power in a
study is 80% and therefore the authors concluded that many
type II errors were likely to continue to occur in the orthopedic
literature thereby affecting critical future research. Type II
errors occur because there are too few subjects, but they also
occur because there are too many measurements made on too
few subjects. If you measure two groups of subjects twice, it is
likely that some of the measurements taken on the second
occasion will be different. It is also possible to show that the
differences are indeed statistically different, if no downwardadjustments are made to the level of significance to compensate
for the fact that there were multiple measurements.
One example of spurious associations being made is in the
field of genetic polymorphisms. In 2007 one researcher
examined why so many statistically significant associations
between diseases in genetic polymorphisms are not replicated
in future studies [12]. Specifically this paper looked at 10 single
nucleotide polymorphisms or SNPs of the COMT gene that
have been associated with various specific diseases. The
authors concluded that false positive findings are commonplace
and initial associations between genetic SNPs and diseases
must be interpreted with high caution, since they are frequently
not replicated. In 2006, a group of researchers conducted a
meta-analysis on the topic of false positive gene associations,
specifically those associated with human lymphocyte disease
[13]. These researchers suggested that a median sample size of
over 3500 subjects was necessary to avoid false positive results.
They went on to state that collaborative studies seem like a
logical approach for collecting large data sets like this, since
individual researchers often do not have the resources to gather
such a large data set themselves. A 2010 paper suggested a
statistical standard be developed before initial results are
accepted [14]. This paper suggested that a true report
probability (TRP) score be developed based on data from
multiple studies. The authors suggested that the suggested TRP
formula would be straightforward and appropriate and help
distinguish spurious results from true results.
HINT 13: Remember that ‘‘associations never prove
causality.’’ This is certainly appropriate when trying to link
genetic polymorphisms and disease, so replicate, replicate, and
replicate.
14. Failure to point out the weaknesses of your own
study
In the last phase of a clinical trial, the results are written in a
manuscript form and submitted for review. Many novice
researchers fail to point out the weaknesses of their own study
in the discussion section of their manuscript. This is often
reason for rejection of the manuscript.
HINT 14: In general hiding your mistakes or obfuscating
them with the hope that no one will notice is not a good policy.
Keep in mind that ‘‘honesty is the best policy’’ holds here as
well.
15. Failure to understand and use correct scientific
language
Finally all researchers, experienced and novices must use the
correct scientific language when describing their results.
Specifically, a single study never proves that a hypothesis is
true; it can only reject the null hypothesis.While most people are
not comfortable using such cautionary language, this is the
correct scientific language. This understanding begins with
studying a good statistical textbook which focuses on clinical
research design [15]. Actually very few research manuscripts
formally state the null hypothesis in themethod section, and then
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section, but when this is done it shows a true understanding of
scientific research and the limitations of the scientific method.
HINT 15: If you want to be a good researcher, you must
study and understand the nuances of the language associated
with the scientific process and only by doing this will you also
understand the limitations of this process.
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